Market Overview

UPDATE: Credit Suisse Raises PT to $41 on HCA Holdings on Positive Reform Exposure

Share:
Related HCA
Companies That Have The Most To Lose If Obamacare Is Repealed
Watch These 7 Huge Call Purchases In Wednesday Trade

Credit Suisse maintained HCA Holdings (NYSE: HCA) with a Market Perform rating and raised the price target from $30.00 to $39.00.

Credit Suisse noted, "HCA reported 4Q12 EPS of $0.91, well ahead of consensus of $0.82 and ahead of our $0.89 estimate, driven by strong organic volume growth. The company also issued 2013 guidance that fell below consensus, which was not overly surprising. However, shares traded off early highs as mgmt provided somewhat reserved commentary around healthcare reform, pointing to many uncertainties that still exist, and the likelihood of a multi-yr ramp. We continue to believe reform will be a meaningful positive in 2014 and the 4Q results reinforce the strong market position and execution by HCA."

HCA Holdings closed at $37.51 on Tuesday.

Latest Ratings for HCA

DateFirmActionFromTo
Jan 2017PiperJaffrayInitiates Coverage OnOverweight
Nov 2016MizuhoDowngradesBuyNeutral
Nov 2016Avondale PartnersDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCA)

View Comments and Join the Discussion!